Research Article
ATR Inhibitor Synergizes PARP Inhibitor Cytotoxicity in Homologous Recombination Repair Deficiency TK6 Cell Lines
Figure 4
The combination of olaparib and AZD6738 decreases the cell survival. Percent survivals are displayed for each indicated genotype treated with olaparib and/or AZD6738. The experiments were performed in triplicate with two independent experiments. Averages and standard deviations are shown.